CPT testing is an aid to clinical judgement, not a replacement for it. The DSM-5-TR diagnostic process for ADHD relies on clinical interview, history, multiple-source rating scales, and functional impairment — none of which a CPT alone can replace. But CPT does add information that interview and rating scales don't capture, and clinicians who use it routinely report several specific use-cases where it changes management.

Where CPT adds value

1. Disambiguating presentations with confounding factors

When a patient's symptoms could fit ADHD, anxiety, depression, sleep disorder, or some combination, CPT can provide a measurement that interview alone can't. Specifically: high RT variability with normal mean performance is highly characteristic of ADHD and is not a typical anxiety, depression, or sleep-deprivation pattern. A patient with subjective attention complaints whose CPT shows normal performance — including normal RTV — is more likely to have a non-ADHD attention problem.

2. Quantitative outcome measure for titration

Subjective titration relies on patient self-report, rating scale change, and functional outcomes. CPT provides a quantitative measure that can be tracked across visits at consistent time-of-day. Within-subject change pre-/post-medication is often more meaningful than absolute percentile values: a 30% RTV reduction on medication is a strong response signal regardless of where the patient sits on population norms.

3. Higher-functioning adults with subtle presentations

Adults with intelligence and compensation strategies can perform well on rating scales and present articulately in interview while still having significant ADHD-related attention dysfunction. CPT performance is harder to compensate for — particularly RTV, which captures lapsing rather than capability.

4. Establishing a baseline before treatment

Even when CPT isn't planned for routine follow-up, a baseline before starting treatment provides an objective comparator if response becomes ambiguous later. "We saw a 40% reduction in commission errors at 8 weeks on Vyvanse 50 mg" is a quantitatively defensible response statement.

5. Patient communication and engagement

A percentile chart with the patient's pre-treatment scores plotted against population norms can be a powerful communication tool — both for explaining the diagnosis and for showing treatment response. Some clinicians report this is one of the highest-value uses, independent of any quantitative diagnostic addition.

Where CPT doesn't add value

  • Rule-in diagnosis on its own. A "positive" CPT alone does not establish ADHD. Many non-ADHD conditions (sleep, anxiety, depression, head injury, certain medications) elevate CPT scores.
  • Rule-out on its own. A "negative" CPT alone does not rule out ADHD — particularly in higher-functioning patients with strong compensatory strategies, time-of-day favorable to alertness, or task-novelty-driven engagement.
  • Replacing developmental history. The childhood-onset criterion can only come from history, not testing.
  • Distinguishing ADHD subtypes definitively. Error patterns are suggestive but not diagnostic of presentation type.

Common workflow patterns

Workflow A: baseline + post-titration

CPT at intake (medication-off if not yet started); repeat at 8–12 weeks once on stable dose. Compare within-subject change. This is the highest-yield, lowest-effort workflow.

Workflow B: at-intake screening

CPT routinely at first ADHD assessment for adults; results integrated alongside interview, ASRS/Conners, and history. Useful for clinicians who want a baseline regardless of titration plans.

Workflow C: titration-driven only

CPT only at decision points — when raising/lowering dose isn't producing expected subjective response, or when patient is uncertain. Lower volume, more targeted.

Workflow D: longitudinal annual

For patients on long-term treatment, an annual CPT to verify continued objective benefit. Particularly useful for patients in long-term stimulant therapy where periodic re-evaluation is appropriate.

Operational considerations

  • In-clinic vs. remote administration. In-clinic offers standardization but requires equipment and protected time. Remote (e.g., QbCheck, AxonCPT) offers flexibility but adds environmental variability. The trade-off depends on practice volume and patient population.
  • Time-of-day standardization. If using CPT for longitudinal tracking, schedule consistently — morning vs. afternoon performance differs, particularly with stimulants.
  • Medication state. Document whether each test is medication-on or medication-off. Both are useful but answer different questions.
  • Sleep & engagement check. Brief pre-test sleep / engagement questionnaire helps interpret poor performance.

Communicating results to patients

Three patterns work well:

  1. Frame as a measurement, not a diagnosis. "This is one piece of data alongside our conversation. Your scores show X, which fits the picture from your history."
  2. Use the percentile graph. Visual representation lands more reliably than verbal descriptions of metrics.
  3. Show the change, not just the level. Pre-/post-treatment comparison is the most clinically meaningful output for patients.

What it isn't

CPT is not a brain scan. It doesn't measure dopamine, doesn't visualize structure, doesn't tell you whether a patient "really has" ADHD in some deeper sense. It measures performance on a specific cognitive task. That measurement, combined with everything else you do clinically, can make the assessment and titration process more grounded — but only as one input among many.

Compare available CPT tools in the comparison table or use the score calculator to ballpark percentile values from raw scores.